Stock Events

Stock Events

Allergy Therapeutics 

€0.12
0
+€0+0% Friday 06:00

Statistics

Day High
0.12
Day Low
0.12
52W High
0.14
52W Low
0.07
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

31MarExpected
Q4 2025
-0
0.33
0.66
1
Expected EPS
-0.004424662847999999
Actual EPS
-0.004424662847999999

People Also Follow

This list is based on the watchlists of people on Stock Events who follow HHU.MU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Alaska Air Group
ALK
Mkt Cap4.53B
ALK-Abelló is a leading company in the field of allergy immunotherapy, directly competing with Allergy Therapeutics in developing treatments for allergic conditions.
Regeneron Pharmaceuticals
REGN
Mkt Cap79.17B
Regeneron Pharmaceuticals, through its development of Dupixent for various allergic conditions, competes in the allergy treatment market, impacting companies like Allergy Therapeutics.
Sanofi
SNY
Mkt Cap113.88B
Sanofi, in partnership with Regeneron, markets Dupixent, a direct competitor in the allergy treatment space, affecting Allergy Therapeutics' market share.
Novavax
NVAX
Mkt Cap1.32B
Novavax is involved in the development of vaccines that could prevent allergic reactions, indirectly competing with Allergy Therapeutics' approach to allergy management.
Merck
MRK
Mkt Cap300.2B
Merck & Co., with its range of allergy and asthma treatments, competes in the broader market for allergic condition management, impacting Allergy Therapeutics.
Astrazeneca
AZN
Mkt Cap316.3B
AstraZeneca offers several products for respiratory and allergic conditions, competing in the same therapeutic area as Allergy Therapeutics.
GSK
GSK
Mkt Cap116.3B
GlaxoSmithKline produces a variety of medications for asthma and allergic rhinitis, competing with Allergy Therapeutics in the respiratory and allergy medication market.

About

Allergy Therapeutics plc, a commercial biotechnology company, focuses on the diagnosis and treatment of allergic disorders in Germany, Austria, United Kingdom, Netherlands, Switzerland, Italy, Spain, and internationally. The company sells injectable and sublingual allergen-specific immunotherapies, and offers treatment of pollen-related allergies, particularly to grasses, weeds, and trees, as well as diagnostics products. Its products include Pollinex Quattro, Oralvac, Venomil, Venom ATL Polistes Dominula, Synbiotics, and Acarovac Plus. It also develops Grass MATA MPL, a subcutaneous allergen-specific immunotherapy candidate that aims to address the cause of symptoms of allergic rhinoconjunctivitis due to grass pollen; and VLP Peanut, a short-course peanut allergy vaccine. Allergy Therapeutics plc was founded in 1998 and is headquartered in Worthing, the United Kingdom.
Show more...
CEO
Mr. Manuel Llobet
Employees
584
Country
Germany
ISIN
GB00B02LCQ05

Listings

STU
DE
HHU.STU
F
DE
HHU.F
MU
DE
HHU.MU
LSE
GB
AGY.LSE

0 Comments

Share your thoughts

FAQ

What is Allergy Therapeutics stock price today?▼
The current price of HHU.MU is €0.12 EUR — it has increased by +0% in the past 24 hours. Watch Allergy Therapeutics stock price performance more closely on the chart.
What is Allergy Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Allergy Therapeutics stocks are traded under the ticker HHU.MU.
When is the next Allergy Therapeutics earnings date?▼
Allergy Therapeutics is going to release the next earnings report on September 24, 2026.
What were Allergy Therapeutics earnings last quarter?▼
HHU.MU earnings for the last quarter are -0 EUR per share, whereas the estimation was -0 EUR resulting in a +0% surprise. The estimated earnings for the next quarter are N/A EUR per share.
How many employees does Allergy Therapeutics have?▼
As of April 13, 2026, the company has 584 employees.
In which sector is Allergy Therapeutics located?▼
Allergy Therapeutics operates in the Health & Wellness sector.
When did Allergy Therapeutics complete a stock split?▼
Allergy Therapeutics has not had any recent stock splits.
Where is Allergy Therapeutics headquartered?▼
Allergy Therapeutics is headquartered in Worthing, Germany.